The Journal of Clinical Psychiatry

Original Research November 18, 2026

Resting State Functional Connectivity in Women With Depression Following Pregnenolone Administration

; ; ; ; ; ; ; ; ; ;

J Clin Psychiatry. 2026;87(4):26m16360

Abstract

Background: Neurosteroids, such as pregnenolone, have potential in mood disorder treatment. Because depression is associated with dysregulated connectivity in brain networks, a systems-level biomarker for neurosteroids modulation of large-scale brain networks can offer critical insight into circuits underlying treatment response. To our knowledge, no studies have examined resting-state functional connectivity (rsFC) in people with depression following pregnenolone administration.

Methods: In this crossover design study conducted between 2019–2021, women (n=29, mean age=45.6 years) with major depressive disorder (DSM-5) were randomized to 7 days of oral pregnenolone 500 mg/d, pregnenolone 800 mg/d, and placebo with a 14-day washout between conditions. After each treatment, steroid levels and resting-state fMRI (rsfMRI) data were collected. A seed-based voxel-wise analysis, with bilateral amygdala as seed, investigated rsFC alterations following treatment conditions in a per-protocol sample (n=11).

Results: Compared to placebo, pregnenolone 500 mg/d was associated with decreased connectivity between the bilateral amygdala and left frontal pole (PFDR=.011). Difference in amygdala connectivity between pregnenolone 800 mg/d and placebo was nonsignificant. Allopregnanolone serum levels increased significantly with administration of either pregnenolone dose as compared to placebo.

Conclusions: Findings suggest that pregnenolone 500 mg/d was associated with decreased connectivity between the amygdala and frontal pole, brain regions pertinent to depression and cognitive control. Presence of rsFC changes at 500 mg/d but not 800 mg/d suggests an inverted-U dose–response pattern, where moderate dosing optimally engages neural circuits compared to higher doses.

Trial Registration: ClinicalTrials.gov identifier: NCT03645096

J Clin Psychiatry 2026;87(4):26m16360

Author affiliations are listed at the end of this article.

From the Editors

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you're already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

  1. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. PubMed CrossRef
  2. Katon W. The impact of depression on workplace functioning and disability costs. Am J Manag Care. 2009;15(11 Suppl):S322–S327. PubMed
  3. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden Of Disease study 2010. PLoS Med. 2013;10(11):e1001547. PubMed CrossRef
  4. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the national Epidemiologic Survey on Alcoholism and Related Conditions. Archives Gen Psychiatry. 2005;62(10):1097–1106. PubMed CrossRef
  5. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105. PubMed CrossRef
  6. Weissman, MM, Leaf, PJ, Holzer, CE, et al. The epidemiology of depression: an update on sex differences in rates. J Affect Disord. 1984;7(3):179–188. PubMed CrossRef
  7. Kuehner C. Why is depression more common among women than among men?. Lancet Psychiatry. 2017;4(2):146–158. PubMed CrossRef
  8. Kornstein SG, Schatzberg AF, Yonkers KA, et al. Gender differences in presentation of chronic major depression. Psychopharmacol Bull. 1995;31(4):711–718. PubMed
  9. Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–137. PubMed CrossRef
  10. Baulieu EE, Robel P. Neurosteroids: a new brain function? J Steroid Biochem Mol Biol. 1990;37(3):395–403. PubMed CrossRef
  11. Meltzer-Brody S, Kanes SJ. Allopregnanolone in postpartum depression: role in pathophysiology and treatment. Neurobiol Stress. 2020;12:100212. PubMed CrossRef
  12. Meltzer-Brody S, Colquhoun H, Riesenberg R, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. PubMed CrossRef
  13. Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry. 2021;78(9):951–959. PubMed CrossRef
  14. Murugan S, Jakka P, Namani S, et al. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. J Biol Chem. 2019;294(12):4596–4607. PubMed CrossRef
  15. George MS, Guidotti A, Rubinow D, et al. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry. 1994;35(10):775–780. PubMed CrossRef
  16. Osuji IJ, Vera-Bolaños E, Carmody TJ, et al. Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Res. 2010;178(2):309–312. PubMed CrossRef
  17. Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867–2873. PubMed CrossRef
  18. Sripada RK, Welsh RC, Marx CE, et al. The neurosteroids allopregnanolone and dehydroepiandrosterone modulate resting-state amygdala connectivity. Hum Brain Mapp. 2014;35(7):3249–3261. PubMed CrossRef
  19. Wang X, Nie X, Zhang F, et al. Functional magnetic resonance imaging of depression: a bibliometrics and meta-analysis. Ann Gen Psychiatry. 2024;23(1):39. PubMed CrossRef
  20. Deligiannidis KM, Fales CL, Kroll-Desrosiers AR, et al. Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology. 2019;44(3):546–554. PubMed CrossRef
  21. Guard M, Labonte AK, Mendoza M, et al. Brexanolone treatment in a real-world patient population: a case series and pilot feasibility study of precision neuroimaging. J Clin Psychopharmacol. 2024;44(3):240–249. PubMed CrossRef
  22. Sripada RK, Marx CE, King AP, et al. DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli. Neuropsychopharmacology. 2013;38(9):1798–1807. PubMed CrossRef
  23. Sripada RK, Marx CE, King AP, et al. Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biol Psychiatry. 2013;73(11):1045–1053. PubMed CrossRef
  24. van Wingen GA, van Broekhoven F, Verkes RJ, et al. Progesterone selectively increases amygdala reactivity in women. Mol Psychiatr. 2008;13(3):325–333. PubMed CrossRef
  25. McGavack TH. ACTH, cortisone and pregnenolone in arthritis and allied diseases. Geriatrics. 1952;7(2):99–108. PubMed
  26. Freeman H, Pincus G. Oral steroid administration in rheumatoid arthritis. J Clin Endocrinol Metab. 1950;10(7):824. PubMed
  27. Marx CE, Trost WT, Shampine L, et al. Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology. 2006;186(3):462–472. PubMed CrossRef
  28. Marx, CE , Trost, WT, Shampine, LJ, et al. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer’s disease. Biol Psychiatry. 2006;60(12):1287–1294. PubMed CrossRef
  29. Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343–381. PubMed
  30. Sergerie K, Chochol C, Armony JL. The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev. 2008;32(4):811–830. PubMed CrossRef
  31. Berboth S, Morawetz C. Amygdala-prefrontal connectivity during emotion regulation: a meta-analysis of psychophysiological interactions. Neuropsychologia. 2021;153:107767. PubMed CrossRef
  32. Bramson B, Folloni D, Verhagen L, et al. Human lateral frontal pole contributes to control over emotional approach–avoidance actions. J Neurosci. 2020;40(14): 2925–2934. PubMed CrossRef
  33. Paulus FW, Ohmann S, Möhler E, et al. Emotional dysregulation in children and adolescents with psychiatric disorders. A narrative review. Front Psychiatry. 2021;12:628252. PubMed CrossRef
  34. Thiebaut de Schotten M, Dell’Acqua F, Valabregue R, et al. Monkey to human comparative anatomy of the frontal lobe association tracts. Cortex. 2012;48(1):82–96. PubMed CrossRef
  35. Von Der Heide RJ, Skipper LM, Klobusicky E, et al. Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain. 2013;136(Pt 6): 1692–1707. PubMed CrossRef
  36. Xu EP, Nguyen L, Leibenluft E, et al. A meta-analysis on the uncinate fasciculus in depression. Psychol Med. 2023;53(7):2721–2731. PubMed CrossRef
  37. Beauchamp MH, Ormerod BK, Jhamandas K, et al. Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol, Biochem Behav. 2000;67(1):29–35. PubMed CrossRef
  38. Meziane H, Mathis C, Paul SM, et al. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology. 1996;126(4): 323–330. PubMed CrossRef
  39. Andréen L, Sundström-Poromaa I, Bixo M, et al. Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology. 2006;187(2):209–221. PubMed CrossRef
  40. Sigel E, Baur R. Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes. J Neurosci. 1988;8(1): 289–295. PubMed
  41. Wang DS, Lu SY, Hong Z, et al. Biphasic action of midazolam on GABAA receptor-mediated responses in rat sacral dorsal commissural neurons. Biochem Biophys Res Commun. 2003;309(4):893–899. PubMed CrossRef
  42. Gjedde A, Kumakura Y, Cumming P, et al. Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci. 2010;107(8):3870–3875. PubMed CrossRef
  43. Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci. 2012;109(16):5995–5999. PubMed CrossRef
  44. Naylor, JC , Kilts, JD, Shampine, LJ, et al. Effect of pregnenolone vs placebo on self-reported chronic low back pain among US military veterans: a randomized clinical trial. JAMA Netw Open. 2020;3(3):e200287. PubMed CrossRef
  45. Marx CE, Lee J, Subramaniam M, et al. Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia. Psychopharmacology. 2014;231(17): 3647–3662. PubMed CrossRef
  46. Milivojevic V, Charron L, Fogelman N, et al. Pregnenolone reduces stress-induced craving, anxiety, and autonomic arousal in individuals with cocaine use disorder. Biomolecules. 2022;12(11):1593. PubMed CrossRef
Buy PDF for $40

Please sign in or purchase this PDF for $40.